Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene (Q41132508)
Jump to navigation
Jump to search
scientific article published on January 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene |
scientific article published on January 1997 |
Statements
1 reference
Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene (English)
1 reference
Sato M
1 reference
Kawamata H
1 reference
Harada K
1 reference
Nakashiro K
1 reference
Ikeda Y
1 reference
Gohda H
1 reference
Yoshida H
1 reference
Nishida T
1 reference
Ono K
1 reference
Kinoshita M
1 reference
Adachi M
1 reference
1 January 1997
1 reference
1 reference
112
1 reference
2
1 reference
181-189
1 reference
Identifiers
1 reference
1 reference